用于帕金森病患者综合症状管理的移动应用程序:试点可用性研究
JuHee Lee1, Yujin Suh, Eunyoung Kim
1Author Affiliations: Mo-Im Kim Nursing Research Institute, Yonsei Evidence Based Nursing Centre of Korea: A Joanna Briggs Institute of Excellence, College of Nursing, Yonsei University (Dr Lee), Seoul; College of Nursing, Health Science & Human Ecology, Dong-Eui University (Dr Suh), Busan; and Graduate School, Brain Korea 21 FOUR Project, College of Nursing, Yonsei University (Mss E. Kim and Yoo); and Division of Nursing, Severance Hospital, Yonsei University Health System (Dr Y. Kim), Seoul, South Korea.
Computers, informatics, nursing : CIN
|January 23, 2024
概括
一个新的移动应用程序帮助帕金森病患者管理非运动症状,提高自我效能和药物坚持. 这种可访问的健康平台促进症状自我监测,以获得更好的护理.
科学领域:
- 神经学 神经学
- 数字健康数字健康
- 移动卫生干预行动 移动卫生干预行动
背景情况:
- 帕金森病的管理需要可访问的平台,以全面跟踪症状.
- 非运动症状往往是主观的,难以监测,现有的移动解决方案很少.
- 对于帕金森病患者的综合移动健康工具的需求越来越大.
研究的目的:
- 开发和评估一个用于全面帕金森病症状管理的移动应用程序.
- 为帕金森病患者评估新型移动健康平台的可用性和可行性.
- 调查移动应用程序对帕金森病自我效能和药物坚持的影响.
主要方法:
- 采用单组重复测量的实验设计.
- 22名参与者使用该应用程序六周,包括非运动症状监测,运动症状游戏和药物管理.
- 数据收集包括在线问卷调查以获得定量结果和电话采访以获得定性见解.
主要成果:
- 参与者报告说,通过自我监测,自我效能 (Z = -3.634,P < .001) 和药物坚持 (Z = -3.371,P = .001) 得到改善.
- 关键的促进者包括一个直观的界面,引人入胜的内容和药物提醒.
- 发现的障碍是遗忘和数字素养和手机使用的挑战.
结论:
- 该研究提供了关于移动技术在帕金森病管理中的可接受性和可用性的见解.
- 初步发现表明,对自我效能和药物坚持有积极影响,指导未来的移动保健护理干预.
- 这种方法可以通过赋予患者症状自我监测的能力来增强帕金森病的治疗连续性.
相关概念视频
Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
Parkinson's Disease: Overview
547
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
547


